Antiretroviral Resistance at Virological Failure in the Neat 001/Anrs 143 Trial: Raltegravir plus Darunavir/Ritonavir or Tenofovir/Emtricitabine plus Darunavir/Ritonavir as First-Line Art
AuthID
P-00M-0CR
P-00M-0CR